Navigation Links
Cempra, Inc. to Report Third Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on November 8, 2012
Date:11/1/2012

CHAPEL HILL, N.C., Nov. 1, 2012 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) today announced that it will report third quarter 2012 financial results and provide a business update after the close of U.S. financial markets on November 8, 2012. Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra will host a conference call and webcast at 4:30 p.m. EST, November 8, 2012.

The conference call may be accessed by dialing 877-377-7553 for domestic callers and 253-237-1151 for international callers. Please specify to the operator that you would like to join the "Cempra, Inc., Third Quarter 2012 Financial Results Call, conference ID#: 59073336." The conference call will be webcast live under the investor relations section of Cempra's website at www.cempra.com, and will be archived there for 30 days following the call. Please visit Cempra's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Cempra, Inc.
Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates have both completed oral Phase 2 clinical trials and seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to utilize its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about Cempra can be found at www.cempra.com.

Investor and Media Contacts:
Robert E. Flamm, Ph.D.
Russo Partners, LLC
(212) 845-4226 
Robert.flamm@russopartnersllc.com

Andreas Marathovouniotis
Russo Partners, LLC
(212) 845-4235
Andreas.marathis@russopartnersllc.com


'/>"/>
SOURCE Cempra, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cempra, Inc., to Present at 2012 Stifel Nicolaus Healthcare Conference and NewsMakers in the Biotech Industry Conference
2. Cempra, Inc. Reports Second Quarter 2012 Financial and Operating Results
3. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
4. Cempra, Inc. to Report Second Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on August 8, 2012
5. Cempra, Inc. to Present at the Global Technology Community 9th Anti-Infectives Partnering and Deal-Making Conference
6. Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on May 10, 2012
7. Solta Medical Reports Third Quarter Results
8. United Therapeutics Corporation Reports Third Quarter 2012 Financial Results
9. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
10. STAAR Surgical Reports Third Quarter 2012 Financial Results
11. Global IP Automation Market 2011 - 2015: MarketResearchReports.Biz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , 22. März 2017   VWR ... weltweit tätige Anbieter von Produkten und Dienstleistungen ... Erwerb von EPL Archives Inc. bekannt, eines ... Kunden im kompletten Zyklus regulierter Forschung, Entwicklung ... Proben, Speicherung von Dokumenten und Zusatzdienstleistungen zur ...
(Date:3/22/2017)... March 22, 2017 TapImmune, Inc. ... in the development of innovative peptide and gene-based ... disease, today announced that it will participate in ... Dr. Glynn Wilson , Chairman and CEO ... company,s business, clinical pipeline and partnering opportunities for ...
(Date:3/22/2017)... March 22, 2017 A new independent ... is the proven ultraviolet-C (UV-C) disinfection solution of ... (HAIs). Published in the March ... Control , the peer-reviewed study of UV-C disinfection ... Vancouver General Hospital and Rochester General Hospital. According ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy and ... published author Bonetta Rose, a wife, mother and grandmother committed to sharing her many ... Publishing, Bonetta Rose‘s new book presents actual events in the life of her family, ...
(Date:3/23/2017)... , ... March 23, 2017 , ... “The Trainer”: ... of published author, Scotty, a fiction writer with an active imagination and an enthusiasm ... new book follows the tale of Wild Bill Hart, who sat looking at the ...
(Date:3/22/2017)... ... March 23, 2017 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had won the ... place at the Suntec Singapore International Exhibition & Convention Centre, Singapore. The award ...
(Date:3/22/2017)... ... March 22, 2017 , ... Soriant recognizes that ... bypasses that. Healthcare facilities across the country are always forced to focus ... and hospitals, across the country, an efficient and quick way to estimate savings ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome Research ... neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by ... exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect in ...
Breaking Medicine News(10 mins):